BRITTANY POST: Open Payments
NPI 1538493523 · KALAMAZOO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$486 in 23 payments from 9 companies in 2025. Trend: 2023 $225 · 2024 $380 · 2025 $486
Food & beverage: $486
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 6 | $127 |
| Exeltis, USA Inc. | 5 | $102 |
| Biogen, Inc. | 4 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $52 |
| Organon LLC | 2 | $48 |
| Exact Sciences Corporation | 1 | $30 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Davol Inc. | 1 | $16 |
| CooperSurgical, Inc. | 1 | $15 |
Products named: Veozah, SLYND, ZURZUVAE, NEXPLANON, Cologuard Collection Kit, Lynkuet, Mirena, INJECTAFER.
Industry payments across MI — which companies pay providers there.
